Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state.
暂无分享,去创建一个
G. Edwards | C. Porter | W. Charman | G A Edwards | C J Porter | W N Charman | A. Humberstone | A J Humberstone
[1] C. Broom. Human pharmacokinetics of halofantrine hydrochloride , 1989 .
[2] M. Rudling,et al. Lipoproteins and microemulsions as carriers of therapeutic and chemical agents. , 1991 .
[3] K. Wasan,et al. Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. , 1998, Journal of pharmaceutical sciences.
[4] C. Porter,et al. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine. , 1996, Journal of pharmaceutical sciences.
[5] C. Porter,et al. A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions. , 1995, Journal of pharmaceutical and biomedical analysis.
[6] C. Porter,et al. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. , 1996, Journal of pharmaceutical sciences.
[7] G. Edwards,et al. Pharmacokinetics of halofantrine in healthy Thai volunteers [letter] , 1991 .
[8] D. Kyle,et al. Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria. , 1993, British journal of clinical pharmacology.
[9] J. Meyer,et al. The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum. , 1995, British journal of clinical pharmacology.
[10] M. J. Chapman. [3] Comparative analysis of mammalian plasma lipoproteins , 1986 .
[11] A. Cowman,et al. Effect of altered serum lipid concentrations on the IC50 of halofantrine against Plasmodium falciparum. , 1998, Journal of pharmaceutical sciences.